ALCAR does this too, but additionally crosses the blood-brain barrier and donates its acetyl group for acetylcholine synthesis in the brain
C., Wunschmann, J., Lendzian, K

doi: 10.34172/apb.43672 Original Article Zhipeng Zhang Data curation, Formal analysis, Resources, Software, Validation, Visualization, Writing original draft, Writing review & editing, 1, 2 Yanqin Ma Conceptualization, 2 Cheng Xie Resources, 2 Yan He Conceptualization, 2 Dong Wang Visualization, 2 Huaien Song Conceptualization, 2 Miao Yuan Data curation, Software, 3 Xiaomei Zhang Writing review & editing, 1, * Author information: 1 Laboratory of Pharmaceutical Engineering, School of Life Science and Health Engineering, Jiangnan University, Jiangnan University, Wuxi, China 2 Suzhou Hepa Thera Biopharmaceutical Co., Ltd., Shanghai, China 3 WuXi AppTec (Shanghai) Ltd., China Abstract Purpose: The objective of this study was to develop and produce a novel fusion protein that combines GLP-1 (glucagon-like peptide-1) and FGF21 (fibroblast growth factor 21), with the aim of achieving synergistic pharmacological effects through the targeting of dual pathways, followed by validation of these effects in a non-alcoholic steatohepatitis (NASH) model

Precise Concentrations : GHK-Cu 7.59 mg/mL, BPC-157 2.39 mg/mL, TB-500 1.99 mg/mL
Whatever the occasion, youll find nourishing, feel-good options to help you eat well and care for yourself
Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made